accountSILVER SPRING, Md. (Reuters) - Eli Lilly and Co and Daiichi Sankyo Co Ltd won unanimous support from a U.S. panel Tuesday for a new blood thinner that would compete with the world's second...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to U.S. panel backs Lilly, Daiichi anti-clotting drug
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account